BioCryst Pharmaceuticals | BCRX - Current Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals reported $516.5M in Current Assets for its fiscal quarter ending in December of 2022.


Current Assets Change
Alnylam Pharmaceuticals ALNY:US USD 2.54B 151.23M
Chugai Pharma 4519:JP JPY 1.23T 109.55B
Daiichi Sankyo 4568:JP JPY 1.5T 57.44B
DBV Technologies DBVT:US USD 210.24M 12.84M
Enanta Pharmaceuticals ENTA:US USD 271.14M 12.57M
Gilead Sciences GILD:US USD 14.37B 855M
GlaxoSmithKline GSK:LN GBP 19.72B 1.05B
Glaxosmithkline GSK:US GBP 19.72B 1.05B
Incyte Corp INCY:US USD 3.97B 121.22M
Intra Cellular Therapies ITCI:US USD 706.09M 31.86M
Ionis Pharmaceuticals IONS:US USD 2.54B 339.92M
Karyopharm Therapeutics KPTI:US USD 318.54M 37.93M
Mirati Therapeutics MRTX:US USD 939.35M 169.61M
Neurocrine Biosciences NBIX:US USD 1.43B 20.7M
Novavax NVAX:US USD 971.03M 732.36M
PTC Therapeutics PTCT:US USD 613.39M 80.39M
Regeneron Pharmaceuticals REGN:US USD 16.91B 1.03B
Roche Holding ROG:VX CHF 33.82B 3.5B
Sarepta Therapeutics SRPT:US USD 2.49B 69.48M
Ultragenyx Pharmaceutical RARE:US USD 766.34M 117.56M
Vertex Pharmaceuticals VRTX:US USD 12.97B 269.1M